(1-methylimidazol-4-yl)methyl 2-methyl-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanoate;2-methyl-N-(oxolan-3-yl)-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanamide
C55H49F6N9O4 — CID 87217199
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1-methylimidazol-4-yl)methyl 2-methyl-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanoate;2-methyl-N-(oxolan-3-yl)-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanamide
(1-methylimidazol-4-yl)methyl 2-methyl-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanoate;2-methyl-N-(oxolan-3-yl)-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanamide (PubChem CID 87217199) has the molecular formula C55H49F6N9O4 and a molecular weight of 1014.04 g/mol. Its IUPAC name is (1-methylimidazol-4-yl)methyl 2-methyl-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanoate;2-methyl-N-(oxolan-3-yl)-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanamide.
Molecular Properties
| Compound Name | (1-methylimidazol-4-yl)methyl 2-methyl-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanoate;2-methyl-N-(oxolan-3-yl)-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanamide |
|---|---|
| PubChem CID | 87217199 |
| Molecular Formula | C55H49F6N9O4 |
| Molecular Weight | 1014.04 g/mol |
| Exact Mass | 1013.38 |
| IUPAC Name | (1-methylimidazol-4-yl)methyl 2-methyl-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanoate;2-methyl-N-(oxolan-3-yl)-3-phenyl-2-[3-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]propanamide |
| SMILES | CC(Cc1ccccc1)(C(=O)NC1CCOC1)c1ccnc2c(-c3ccc(C(F)(F)F)cc3)cnn12.Cn1cnc(COC(=O)C(C)(Cc2ccccc2)c2ccnc3c(-c4ccc(C(F)(F)F)cc4)cnn23)c1 |
| InChI | InChI=1S/C28H24F3N5O2.C27H25F3N4O2/c1-27(14-19-6-4-3-5-7-19,26(37)38-17-22-16-35(2)18-33-22)24-12-13-32-25-23(15-34-36(24)25)20-8-10-21(11-9-20)28(29,30)31;1-26(15-18-5-3-2-4-6-18,25(35)33-21-12-14-36-17-21)23-11-13-31-24-22(16-32-34(23)24)19-7-9-20(10-8-19)27(28,29)30/h3-13,15-16,18H,14,17H2,1-2H3;2-11,13,16,21H,12,14-15,17H2,1H3,(H,33,35) |
| InChIKey | USABXXOWRAKKID-UHFFFAOYSA-N |
| XLogP | 10.21 |
| TPSA | 142.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1014.04 |
| LogP ≤ 5 | 10.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 87217199 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.